
In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pulled off the market. FDA officials have said they want to withdraw the medication, Makena, because of lack… read on > read on >